Brian R Bettencourt

USPTO Granted Patents = 79 (Patent Applications = 47)

CIPO Patents = 5 (Patent Applications = 19)

EPO Patents = 19 (Patent Applications = 36)

Average Co-Inventor Count = 4.6

ph-index = 10

Forward Citations = 340(Granted Patents)

Forward Citations (Not Self Cited) = 196(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (2013 - 2022)
Groton, MA (US) (2015 - 2024)

Company Filing History:

73 out of 444

Alnylam Pharmaceuticals, Inc.

patents

6 out of 270

Icahn School of Medicine at Mount Sinai

patents

4 out of 96

Arrowhead Pharmaceuticals, Inc.

patents

4. 2 out of 1,210

Dana-Farber-Cancer Institute Inc.

patents

5. 1 out of 1

Triplet Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

iRNA Compositions

Angiopoietin-like 3

Complement Component C5

TMPRSS6 Gene Expression

Ketohexokinase

EPAS1-related Diseases

Transthyretin Amyloidosis

Insulin-like Growth Factor

Serpina1

Nucleotide Repeat Expansion Disorders

Erythropoietin Production

79 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12467051 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2025-11-11),

2. 12071619 - SERPINA1 iRNA compositions and methods of use thereof (2024-08-27),

3. 11873491 - Complement component C5 iRNA compositions and methods of use thereof (2024-01-16),

4. 11866709 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2024-01-09),

5. 11840692 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2023-12-12),

6. 11834662 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2023-12-05),

7. 11525138 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-12-13),

8. 11446380 - Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression (2022-09-20),

9. 11419942 - Angiotensinogen (AGT) iRNA compositions and methods of use thereof (2022-08-23),

10. 11408000 - Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity (2022-08-09),

11. 11332743 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-05-17),

12. 11306316 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

13. 11306315 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

14. 11306314 - Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof (2022-04-19),

15. 11261444 - Organic compositions to treat EPAS1-related diseases (2022-03-01),

Title: The Innovative Journey of Brian R Bettencourt

Introduction: Brian R Bettencourt, a talented inventor hailing from Groton, MA (US), has made significant contributions to the field of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Brian R Bettencourt holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to complex challenges.

Career Highlights: Throughout his career, Brian R Bettencourt has demonstrated a keen ability to identify gaps in the market and develop groundbreaking inventions to fill those voids. His passion for innovation has led to the successful commercialization of several of his patented ideas.

Collaborations: Brian R Bettencourt has collaborated with leading research institutions, universities, and companies to further enhance his inventions and bring them to the market. His collaborative spirit has allowed him to tap into a diverse range of expertise, resulting in truly innovative solutions.

Conclusion: In conclusion, Brian R Bettencourt stands as a shining example of an inventor who has not only transformed ideas into reality but has also made a lasting impact on the world of innovations. His relentless pursuit of excellence and commitment to pushing the boundaries of what is possible continue to inspire aspiring inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.